Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Ping Chang

Matched on ORCID iD 0009-0008-4455-364X; OpenAlex author ID A5102986311. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 11

  1. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. Co-author DOI 10.1016/j.xhgg.2021.100078↗
  2. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study. Co-author DOI 10.1002/ijc.30762↗
  3. RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer. Co-author DOI 10.18632/oncotarget.16451↗
  4. A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. Co-author PMID 28401019↗
  5. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy… Co-author DOI 10.1016/j.ijrobp.2015.10.062↗
  6. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer. Co-author PMID 26693076↗
  7. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0085942↗
  8. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer. Co-author DOI 10.1002/mc.20817↗
  9. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Co-author DOI 10.1016/j.canep.2011.05.013↗
  10. Micronuclei levels in peripheral blood lymphocytes as a potential biomarker for pancreatic cancer risk. Co-author DOI 10.1093/carcin/bgq247↗
  11. Glucose metabolism gene variants modulate the risk of pancreatic cancer. Co-author DOI 10.1158/1940-6207.capr-10-0247↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Donghui Li · 10 shared papers, 2011–2022 · strength 0.57
  2. James L. Abbruzzese · 5 shared papers, 2011–2016 · strength 0.21
  3. Huamin Wang · 2 shared papers, 2017–2022 · strength 0.19
  4. Xiaoqun Dong · 4 shared papers, 2011–2014 · strength 0.15
  5. Manal M. Hassan · 2 shared papers, 2015–2017 · strength 0.13
  6. Yixiang Mao · 2 shared papers, 2015–2017 · strength 0.13
  7. Chad Daniel Huff · 1 shared paper, 2022 · strength 0.12
  8. Paul A Scheet · 1 shared paper, 2022 · strength 0.12
  9. Xifeng Wu · 1 shared paper, 2022 · strength 0.12
  10. Yao Yu · 1 shared paper, 2022 · strength 0.12
  11. Lisa Cannon‐Albright · 1 shared paper, 2022 · strength 0.12
  12. Jennifer B. Permuth · 1 shared paper, 2022 · strength 0.12
  13. Kenneth R. Hess · 3 shared papers, 2011–2012 · strength 0.10
  14. Hongwei Tang · 1 shared paper, 2017 · strength 0.07
  15. Peng Wei · 1 shared paper, 2017 · strength 0.07
  16. Hongwei Tang · 2 shared papers, 2011–2012 · strength 0.06
  17. Chun Te Chen · 1 shared paper, 2017 · strength 0.06
  18. Haoqiang Ying · 1 shared paper, 2017 · strength 0.06
  19. Ronald Anthony Depinho · 1 shared paper, 2017 · strength 0.06
  20. Mien‐Chie Hung · 1 shared paper, 2017 · strength 0.06
  21. Chandan Guha · 1 shared paper, 2016 · strength 0.05
  22. William F. Regine · 1 shared paper, 2016 · strength 0.05
  23. John Parker Hoffman · 1 shared paper, 2016 · strength 0.05
  24. Ross Allen Abrams · 1 shared paper, 2016 · strength 0.05
  25. Howard P. Safran · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.